This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-17 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Bruce Morimoto, PhD
Vice President, Drug Development at Cerecin


Bruce is the Vice President, Scientific Affairs, a key leadership position at Celerion and is directly responsible for developing and deploying scientific, regulatory and medical expertise and advice to various biotech and emerging pharmaceutical companies.  He works closely with subject matter experts across all Celerion business units to provide consulting services and timely input on drug development programs.

 Bruce earned his doctorate in biochemistry from the University of California, Los Angeles (UCLA), and completed post doctorate research at University of California, Berkeley.  He has a Bachelor of Science degree in biochemistry from the University of California, Los Angeles (UCLA)

Agenda Sessions

  • Workshop Moderator’s Welcome and Opening Remarks

  • Best Practices for Nonclinical Peptide Development: Bioanalysis, Pharmacokinetics, and Toxicity